A Phase I Study of OncoLAR® (Registered Trademark) (NSC 685403) With/Without Tamoxifen in Patients With Osteosarcoma
PHASE1CompletedINTERVENTIONAL
Enrollment
24
Participants
Timeline
Start Date
May 31, 1995
Study Completion Date
September 30, 2000
Conditions
Neoplasm MetastasisOsteosarcoma
Interventions
DRUG
OncoLAR® (Registered Trademark)
DRUG
tamoxifen
Trial Locations (1)
20892
National Cancer Institute (NCI), Bethesda
All Listed Sponsors
lead
National Cancer Institute (NCI)
NIH
NCT00001436 - A Phase I Study of OncoLAR® (Registered Trademark) (NSC 685403) With/Without Tamoxifen in Patients With Osteosarcoma | Biotech Hunter | Biotech Hunter